GHK-Cu 50mg

GHK-Cu 50mg is the copper-binding complex of the naturally occurring tripeptide Glycyl-L-histidyl-L-lysine. The 50mg presentation is supplied as a higher-quantity research material for extended research programmes and multi-assay panels.

GHK-Cu has a broad research history spanning cellular signalling, fibroblast biology, extracellular-matrix processes and collagen-related pathways. Its copper-binding characteristics also make it relevant to studies examining how peptide–metal interactions can influence biological systems.

The 50mg quantity is intended to support research workflows that require repeated assays or a larger reference-material supply. Researchers should nevertheless rely on the current product specification and batch documentation for the definitive quantity, purity and analytical information.

Each batch is supplied with a Certificate of Analysis (COA) from independent third-party testing, covering HPLC purity and mass-spectrometry identity. Researchers can use the applicable documentation to support procurement records, compound identification and batch traceability.

Experimental interpretation should remain model-specific. Findings from cell culture, biochemical assays or other preclinical systems should not automatically be presented as evidence of a human clinical effect.

GHK-Cu 50mg is for laboratory research use only. It is not a medicinal product, is not licensed by the MHRA and is not intended for human or veterinary use, diagnosis, treatment or self-administration. Sold only to qualified researchers aged 18 or over.